this post was submitted on 06 Jul 2023
1 points (100.0% liked)

science

136 readers
1 users here now

Discuss the latest science news, original research papers, and connect with fellow enthusiasts.

founded 1 year ago
MODERATORS
 

The UK government has partnered with BioNTech to conduct trials of personalised mRNA-based cancer immunotherapies. These trials aim to provide precision immunotherapies to treat cancer patients and offer personalized treatments for up to 10,000 patients by 2030. BioNTech will establish a regional hub and labs in Cambridge, staffed with over 70 highly skilled scientists. The collaboration will also involve the creation of a Cancer Vaccine Launch Pad (CVLP) to identify eligible patients for potential trials. Clinical trials have already begun, with further enrollment expected from 2026 onwards.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here